JPRN-UMIN000005578已完成2 期
A phase II trial of Neoadjuvant and adjuvant chemotherapy with Gemcitabine and TS-1 combination for patients with locally advanced pancreatic cancer - CAP-003
Chiba study group of adjuvant chemotherapy for pancreatic cancer0 个研究点目标入组 45 人开始时间: 2011年5月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of sever allergic reaction with gemcitabine or s-1 2)Sever myelosuppression 3) Pregnant females, possibly pregnant females, females wishing to become pregnant, and females feeding babies. 4)Serious renal dysfunction 5)Serious liver dysfunction 6)Patients under treatment with other furuorouracil related chemotherapy 7)Patients under treatment with flucytosine. 8)Pulmonary fibrosis or interstitial pneumonia 9)History of breast or lung radiation 10)Active infection 11)Patients with pleural effusion 12)Evidence of distant metastasis 13)Active double cancer 14)Uncontrolled heart diseases such as angina, myocardial infarction within three months, and cardiac dysfunction 15)Uncontrolled diabetes or hypertension 16)Sever mental disorder 17)Inadequate physical condition, as diagnosed by primary physician
研究者
相似试验
招募中
不适用
A phase II study of Neoadjuvant chemotherapy plus Durvalumab (MEDI4736) and Tremelimumab in Advanced-stage ovarian cancer (TRU-D)NeoplasmsKCT0003742Yonsei University Health System, Severance Hospital24
进行中（未招募）
1 期
Study of chemotherapy and immunotherapy for patients with lung cancer bounded in the thorax and potentially resectableon-small cell lung cancerMedDRA version: 20.0 Level: LLT Classification code 10029514 Term: Non-small cell lung cancer NOS System Organ Class: 100000004864EUCTR2018-004515-45-ESFundación GECP90
进行中（未招募）
1 期
Study of chemotherapy and immunotherapy for patients with lung cancer bounded in the thorax and potentially resectableon-small cell lung cancer (NSCLC)MedDRA version: 21.1Level: LLTClassification code: 10029514Term: Non-small cell lung cancer NOS Class: 10029104CTIS2024-513731-24-00Fundacion GECP90
招募中
不适用
A phase II trial of neoadjuvant chemotherapy with docetaxel,cisplatin and S-1 (DCS) for radically resectable advanced gastric carcinoma (KDOG 1001)radically resectable advanced gastric carcinomaJPRN-UMIN000003642Kitasato University School of Medicine40
未知
2 期
A Phase II trial of neoadjuvant chemotherapy with S-1 and fractional cisplatin for locally advanced gastric cancerGastric cancerJPRN-UMIN000001777Division of Biological Regulation and Oncology, Department of Surgery, Graduate School of Medicine, Tohoku University25